WallStreetZenWallStreetZen

NYSE: RMD
Resmed Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for RMD

Based on 9 analysts offering 12 month price targets for Resmed Inc

Min Forecast
$270.00+9.52%
Avg Forecast
$295.11+19.71%
Max Forecast
$330.00+33.86%

Should I buy or sell RMD stock?

Based on 9 analysts offering ratings for Resmed Inc.

Buy
Strong Buy
3 analysts 33.33%
Buy
3 analysts 33.33%
Hold
3 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although RMD's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates RMD as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their RMD stock forecasts and price targets.

RMD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-11-03
lockedlocked$00.00+00.00%2025-10-31
lockedlocked$00.00+00.00%2025-10-31
lockedlocked$00.00+00.00%2025-10-31
lockedlocked$00.00+00.00%2025-10-21
Wells Fargo
Top 34%
67
HoldInitiates Coverage On$280.00+11.98%2025-10-13
Citigroup
Bottom 19%
19
Strong BuyInitiates Coverage On$330.00+31.98%2025-09-18
Stifel Nicolaus
Bottom 47%
47
HoldMaintains$270.00+7.98%2025-08-01
Piper Sandler
Top 16%
85
HoldMaintains$270.00+7.98%2025-08-01

1 of 1

Forecast return on equity

Is RMD forecast to generate an efficient return?

Company
31.35%
Industry
22.81%
Market
227.38%
RMD's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is RMD forecast to generate an efficient return on assets?

Company
23.1%
Industry
17.06%
RMD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

RMD earnings per share forecast

What is RMD's earnings per share in the next 3 years based on estimates from 22 analysts?

Avg 1 year Forecast
$10.98+11.92%
Avg 2 year Forecast
$12.13+23.67%
Avg 3 year Forecast
$13.15+34.04%
RMD's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

RMD revenue forecast

What is RMD's revenue in the next 3 years based on estimates from 24 analysts?

Avg 1 year Forecast
$5.7B+7.52%
Avg 2 year Forecast
$6.1B+15.4%
Avg 3 year Forecast
$6.5B+23.1%
RMD's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

RMD earnings growth forecast

How is RMD forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
10.35%
Industry
27.37%
Market
42.62%
RMD's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
RMD's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
RMD's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

RMD revenue growth forecast

How is RMD forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
7.19%
Industry
7.89%
Market
25.81%
RMD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
RMD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

RMD vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
RMD$250.04$295.11+18.03%Buy
ALC$78.87$89.96+14.06%Buy
WST$269.08$338.00+25.61%Strong Buy
BDX$189.50$196.50+3.69%Buy
HOLX$74.85$79.10+5.68%Buy
View Top Medical Stocks

Resmed Stock Forecast FAQ

Is Resmed Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NYSE: RMD) stock is to Buy RMD stock.

Out of 9 analysts, 3 (33.33%) are recommending RMD as a Strong Buy, 3 (33.33%) are recommending RMD as a Buy, 3 (33.33%) are recommending RMD as a Hold, 0 (0%) are recommending RMD as a Sell, and 0 (0%) are recommending RMD as a Strong Sell.

If you're new to stock investing, here's how to buy Resmed stock.

What is RMD's earnings growth forecast for 2026-2028?

(NYSE: RMD) Resmed's forecast annual earnings growth rate of 10.35% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 27.25%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.76%.

Resmed's earnings in 2025 is $1,437,904,000.On average, 22 Wall Street analysts forecast RMD's earnings for 2026 to be $1,602,578,538, with the lowest RMD earnings forecast at $1,480,536,120, and the highest RMD earnings forecast at $1,722,241,706. On average, 22 Wall Street analysts forecast RMD's earnings for 2027 to be $1,770,804,692, with the lowest RMD earnings forecast at $1,663,636,239, and the highest RMD earnings forecast at $1,935,118,949.

In 2028, RMD is forecast to generate $1,919,296,203 in earnings, with the lowest earnings forecast at $1,713,702,678 and the highest earnings forecast at $2,128,845,415.

What is RMD's revenue growth forecast for 2026-2028?

(NYSE: RMD) Resmed's forecast annual revenue growth rate of 7.19% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.91%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.81%.

Resmed's revenue in 2025 is $5,257,400,000.On average, 24 Wall Street analysts forecast RMD's revenue for 2026 to be $825,147,459,982, with the lowest RMD revenue forecast at $792,013,111,244, and the highest RMD revenue forecast at $868,645,415,594. On average, 24 Wall Street analysts forecast RMD's revenue for 2027 to be $885,577,505,698, with the lowest RMD revenue forecast at $845,290,808,554, and the highest RMD revenue forecast at $945,277,719,944.

In 2028, RMD is forecast to generate $944,693,854,768 in revenue, with the lowest revenue forecast at $878,133,224,704 and the highest revenue forecast at $1,006,437,597,130.

What is RMD's forecast return on assets (ROA) for 2026-2028?

(NYSE: RMD) forecast ROA is 23.1%, which is higher than the forecast US Medical Instruments & Supplies industry average of 17.12%.

What is RMD's Price Target?

According to 9 Wall Street analysts that have issued a 1 year RMD price target, the average RMD price target is $295.11, with the highest RMD stock price forecast at $330.00 and the lowest RMD stock price forecast at $270.00.

On average, Wall Street analysts predict that Resmed's share price could reach $295.11 by Nov 3, 2026. The average Resmed stock price prediction forecasts a potential upside of 18.03% from the current RMD share price of $250.04.

What is RMD's Earnings Per Share (EPS) forecast for 2026-2028?

(NYSE: RMD) Resmed's current Earnings Per Share (EPS) is $9.81. On average, analysts forecast that RMD's EPS will be $10.98 for 2026, with the lowest EPS forecast at $10.14, and the highest EPS forecast at $11.80. On average, analysts forecast that RMD's EPS will be $12.13 for 2027, with the lowest EPS forecast at $11.40, and the highest EPS forecast at $13.26. In 2028, RMD's EPS is forecast to hit $13.15 (min: $11.74, max: $14.58).

What is RMD's forecast return on equity (ROE) for 2026-2028?

(NYSE: RMD) forecast ROE is 31.35%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.